New recommendations on treating pseudohypoparathyroidism

24 Jan 2022


A review published in the Journal of the Endocrine Society suggests that patients with pseudohypoparathyroidism may require higher doses of levothyroxine and calcitriol than guidelines currently recommend.

Medscape


Related Topics

Thyroid

Share this story